hydroxyurea has been researched along with phosphorus radioisotopes in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (44.68) | 18.7374 |
| 1990's | 16 (34.04) | 18.2507 |
| 2000's | 8 (17.02) | 29.6817 |
| 2010's | 2 (4.26) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dresch, C; Najean, Y; Rain, JD | 1 |
| Roti, LW; Stevens, AR | 1 |
| Balhorn, R; Chalkey, R; Granner, D; Jackson, V | 1 |
| Léhi, M; Nagy, G | 1 |
| Dales, S; Katz, JR; Pogo, BG | 1 |
| Grossi, A; Longo, G; Rafanelli, D; Rossi Ferrini, P; Vannucchi, AM | 1 |
| Degen, MA; Feldman, BF; Goding, B; Kitchell, B; Mandell, CP; Turrel, JM | 1 |
| Aghai, E; Froom, P; Kinarty, A; Lahat, N | 1 |
| Dresch, C; Najean, Y | 1 |
| Berk, PD; Berlin, NI; Donovan, PB; Fruchtman, SM; Goldberg, JD; Wasserman, LR | 1 |
| Landaw, SA | 1 |
| Hewitt, RR; Humphrey, RM; Meyn, RE | 1 |
| Magnusson, G | 1 |
| Laipis, PJ; Levine, AJ | 1 |
| Balhorn, R; Chalkley, R; Granner, D; Tanphaichitr, N | 1 |
| Buhl, SN; Regan, JD; Setlow, RB | 1 |
| Bernard, J; Boiron, M; Briére, J; Bussel, A; Jacquillat, C; Tanzer, J; Weil, M | 1 |
| Craig, N | 1 |
| Kornacka, L; Malec, J; Mościcka, M; Wojnarowska, M | 1 |
| Balhorn, R; Chalkley, R; Granner, DK; Tanphaichitr, N | 1 |
| Ratliff, RL; Tobey, RA; Walters, RA | 1 |
| Bauters, F; Demory, JL; Huart, JJ; Jouet, JP; Simon, M | 1 |
| Jong, AY; Wang, B; Zhang, SQ | 1 |
| Anderson, H; Brandt, L | 1 |
| Najean, Y; Rain, JD; Toubert, ME | 1 |
| Boivin, P | 1 |
| Fisher, SG; Godwin, J; Nand, S; Stock, W | 1 |
| Litz, CE; Woronzoff-Dashkoff, KK | 1 |
| Dresch, C; Echard, M; Goguel, A; Grange, MJ; Lejeune, F; Najean, Y; Rain, JD | 1 |
| Najean, Y; Rain, JD | 1 |
| Berlin, NI; Wasserman, LR | 1 |
| Nevado Reviriego, I; Román Barbero, A; Sánchez Fayos, J | 1 |
| Samuelsson, J | 1 |
| Bauters, F | 1 |
| Fabris, F; Girolami, A; Randi, ML | 2 |
| Silverstein, MN; Tefferi, A | 1 |
| Andréasson, B; Carneskog, J; Kutti, J; Lindstedt, G; Lundberg, PA; Swolin, B; Wadenvik, H | 1 |
| Berlin, NI | 1 |
| Rain, JD | 1 |
| Tefferi, A; Wright, CA | 1 |
| Amiel, A; Bomstein, Y; Fejgin, MD; Gaber, E; Herishanu, Y; Kitay-Cohen, Y; Lishner, M | 1 |
| Dupuy, E; Goguel, A; Grange, MJ; Mougeot-Martin, M; Najean, Y; Rain, JD; Vigneron, N | 1 |
| Solberg, LA | 1 |
| Dingli, D; Tefferi, A | 1 |
| Dowson, A; Frewin, R | 1 |
| Björkholm, M; Derolf, ÅR; Hultcrantz, M | 1 |
11 review(s) available for hydroxyurea and phosphorus radioisotopes
| Article | Year |
|---|---|
[Essential thrombocythemia: conventional therapy].
Topics: Adult; Antineoplastic Agents; Busulfan; Follow-Up Studies; Hemorrhage; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Leukemia; Middle Aged; Phosphorus Radioisotopes; Plateletpheresis; Polycythemia Vera; Risk Factors; Thrombocythemia, Essential; Thrombosis | 1991 |
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Lymphoma; Neoplasms, Radiation-Induced; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Prevalence; Primary Myelofibrosis; Risk; Splenomegaly | 1996 |
[Efficacious treatment of a fatal blood disease: polycythemia vera].
Topics: Acute Disease; Alkylating Agents; Busulfan; Chlorambucil; Humans; Hydroxyurea; Leukemia, Myeloid; Leukemia, Radiation-Induced; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Platelet Aggregation Inhibitors; Polycythemia Vera; Randomized Controlled Trials as Topic; Survival Rate | 1997 |
[Vaquez disease. Diagnosis, course, treatment].
Topics: Aged; Antineoplastic Agents, Alkylating; Antisickling Agents; Diagnosis, Differential; Female; Humans; Hydroxyurea; Injections, Intravenous; Interferon-alpha; Male; Middle Aged; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Risk Factors; Sex Factors | 1998 |
Treatment of polycythaemia vera and essential thrombocythaemia.
Topics: Adult; Aged; Aspirin; Chlorambucil; Disease Progression; Female; Hemorrhage; Humans; Hydroxyurea; Interferon-alpha; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Quinazolines; Thrombocythemia, Essential; Thrombosis | 1998 |
Treatment of the myeloproliferative disorders with 32P.
Topics: Adult; Aged; Alkylating Agents; Chlorambucil; Clinical Trials as Topic; Combined Modality Therapy; Drug Utilization; Humans; Hydroxyurea; Immunologic Factors; Interferons; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Middle Aged; Myeloproliferative Disorders; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera; Radiotherapy; Thrombocythemia, Essential | 2000 |
A single institutional experience with 43 pregnancies in essential thrombocythemia.
Topics: Abortion, Induced; Abortion, Spontaneous; Abruptio Placentae; Adult; Anticoagulants; Aspirin; Busulfan; Erythromelalgia; Female; Fetal Death; Follow-Up Studies; Heparin; Humans; Hydroxyurea; Migraine Disorders; Obstetric Labor, Premature; Phosphorus Radioisotopes; Platelet Aggregation Inhibitors; Platelet Count; Plateletpheresis; Pregnancy; Pregnancy Complications, Hematologic; Pregnancy Outcome; Pregnancy Trimester, First; Pregnancy, Ectopic; Pregnancy, High-Risk; Quinazolines; Retrospective Studies; Risk; Thrombocythemia, Essential; Uterine Hemorrhage | 2001 |
Therapeutic options for essential thrombocythemia and polycythemia vera.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Aspirin; Busulfan; Fibrinolytic Agents; Humans; Hydroxyurea; Immunologic Factors; Immunosuppressive Agents; Interferon-alpha; Nucleic Acid Synthesis Inhibitors; Phosphorus Radioisotopes; Polycythemia Vera; Quinazolines; Risk Assessment; Thrombocytosis | 2002 |
Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.
Topics: Aged; Agranulocytosis; Alkylating Agents; Clinical Trials as Topic; Combined Modality Therapy; Disease Progression; Evidence-Based Medicine; Hemorrhage; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera; Thrombocythemia, Essential; Thrombophilia | 2006 |
Headache in essential thrombocythaemia.
Topics: Alkylating Agents; Analgesics; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Headache Disorders; Humans; Hydroxyurea; Immunologic Factors; Interferon-alpha; Phosphorus Radioisotopes; Platelet Aggregation Inhibitors; Quinazolines; Radiopharmaceuticals; Risk Factors; Thrombocythemia, Essential | 2012 |
Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
Topics: Antineoplastic Agents; Cell Transformation, Neoplastic; Disease Progression; Humans; Hydroxyurea; Janus Kinase 2; Leukemia, Myeloid, Acute; Mutation; Myelodysplastic Syndromes; Phosphorus Radioisotopes; Polycythemia Vera; Primary Myelofibrosis; Survival Analysis; Thrombocythemia, Essential | 2014 |
8 trial(s) available for hydroxyurea and phosphorus radioisotopes
| Article | Year |
|---|---|
Maintenance therapy of 32P-induced remission in polycythemia vera. A clinical trial of chlorambucil and hydroxy-urea in 109 cases.
Topics: Chlorambucil; Drug Tolerance; Humans; Hydroxyurea; Long-Term Care; Phosphorus Radioisotopes; Polycythemia Vera; Time Factors | 1978 |
The choice of treatment in polycythaemia vera.
Topics: Bloodletting; Chlorambucil; Clinical Trials as Topic; Humans; Hydroxyurea; Phosphorus Radioisotopes; Polycythemia Vera; Random Allocation | 1986 |
Therapeutic recommendations in polycythemia vera based on Polycythemia Vera Study Group protocols.
Topics: Acute Disease; Age Factors; Bloodletting; Chlorambucil; Combined Modality Therapy; False Positive Reactions; Follow-Up Studies; Gastrointestinal Neoplasms; Gout; Hematocrit; Humans; Hydroxyurea; Leukemia; Phosphorus Radioisotopes; Platelet Aggregation; Platelet Count; Polycythemia Vera; Prospective Studies; Pruritus; Skin Neoplasms; Thrombosis | 1986 |
[Treatment of polycythemia with 32P with or without hydroxyurea maintenance therapy. Preliminary results in 237 elderly and high vascular risk subjects studied since 1980].
Topics: Age Factors; Aged; Carcinoma; Cardiovascular Diseases; Female; Humans; Hydroxyurea; Injections, Intravenous; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Phosphorus Radioisotopes; Polycythemia; Primary Myelofibrosis; Risk Factors | 1993 |
Indications, procedure and results for the treatment of polycythaemia vera by bleeding, pipobroman and hydroxyurea.
Topics: Acute Disease; Bloodletting; Combined Modality Therapy; Humans; Hydroxyurea; Leukemia; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Splenomegaly; Vascular Diseases | 1993 |
Risk of leukaemia, carcinoma, and myelofibrosis in 32P- or chemotherapy-treated patients with polycythaemia vera: a prospective analysis of 682 cases. The "French Cooperative Group for the Study of Polycythaemias".
Topics: Actuarial Analysis; Acute Disease; Carcinoma; Cause of Death; Disease Progression; Follow-Up Studies; Humans; Hydroxyurea; Incidence; Leukemia, Myeloid; Leukemia, Radiation-Induced; Lymphoma; Neoplasms, Radiation-Induced; Phlebotomy; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Prevalence; Primary Myelofibrosis; Risk; Splenomegaly | 1996 |
Treatment of polycythemia vera: use of 32P alone or in combination with maintenance therapy using hydroxyurea in 461 patients greater than 65 years of age. The French Polycythemia Study Group.
Topics: Actuarial Analysis; Aged; Alkylating Agents; Combined Modality Therapy; Disease Progression; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Radiation-Induced; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Phosphorus Radioisotopes; Polycythemia Vera; Primary Myelofibrosis; Risk; Survival Analysis; Vascular Diseases | 1997 |
[Treatment of polycythemia. I--Using radiophosphorus with or without treatment in 483 patients over 65 years of age].
Topics: Aged; Aged, 80 and over; Combined Modality Therapy; Female; Humans; Hydroxyurea; Leukemia; Male; Phosphorus Radioisotopes; Polycythemia Vera; Prospective Studies; Risk Factors; Survival Rate | 1998 |
29 other study(ies) available for hydroxyurea and phosphorus radioisotopes
| Article | Year |
|---|---|
DNA synthesis in growth and encystment of Acanthamoeba castellanii.
Topics: Animals; DNA; Eukaryota; Floxuridine; Hydroxyurea; Phosphates; Phosphorus Radioisotopes; RNA; Thymidine; Time Factors; Tritium | 1975 |
Phosphorylation of the lysine-rich histones throughout the cell cycle.
Topics: Autoradiography; Carcinoma, Hepatocellular; Cells, Cultured; Demecolcine; DNA, Neoplasm; Electrophoresis; Histones; Hydroxyurea; Liver Neoplasms; Lysine; Mitosis; Neoplasms, Experimental; Phosphates; Phosphoproteins; Phosphoric Monoester Hydrolases; Phosphorus Radioisotopes; Tritium | 1975 |
Cytostatic treatment of polycythaemia rubra vera. Comparison of the effects of some cytostatics in 100 patients in a period of five years.
Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Drug Evaluation; Female; Humans; Hydroxyurea; Male; Mesylates; Middle Aged; Mitobronitol; Phosphorus Radioisotopes; Polycythemia Vera; Remission, Spontaneous | 1975 |
Biogenesis of poxviruses: synthesis and phosphorylation of a basic protein associated with the DNA.
Topics: Amino Acids; Animals; Arginine; DNA Replication; DNA, Viral; Electrophoresis, Polyacrylamide Gel; Hydroxyurea; L Cells; Mice; Molecular Weight; Oxidative Phosphorylation; Peptides; Phosphorus Radioisotopes; Rifampin; Vaccinia virus; Viral Proteins | 1975 |
Thrombocytosis associated with a myeloproliferative disorder in a dog.
Topics: Animals; Blood Platelets; Combined Modality Therapy; Dog Diseases; Dogs; Hydroxyurea; Male; Microscopy, Electron; Myeloproliferative Disorders; Phosphorus Radioisotopes; Radiography; Splenomegaly; Thrombocytosis | 1989 |
Decreased natural killer (NK) activity in patients with myeloproliferative disorders.
Topics: Bloodletting; Humans; Hydroxyurea; Interferon Type I; Interleukin-2; Killer Cells, Natural; Myeloproliferative Disorders; Neoplasms; Phosphorus Radioisotopes; Polycythemia Vera; Primary Myelofibrosis; Thrombocytosis | 1989 |
Acute leukemia in polycythemia vera.
Topics: Acute Disease; Antigens, Neoplasm; Bloodletting; Chlorambucil; Chromosome Aberrations; Chromosome Disorders; Humans; Hydroxyurea; Leukemia; Phosphorus Radioisotopes; Polycythemia Vera; Primary Myelofibrosis; Prospective Studies; Retrospective Studies; Time Factors | 1986 |
Evaluation of S phase synchronization by analysis of DNA replication in 5-bromodeoxyuridine.
Topics: Animals; Autoradiography; Bromodeoxyuridine; Carbon Radioisotopes; Cell Count; Cells, Cultured; Centrifugation, Density Gradient; Cesium; Chlorides; Cricetinae; Culture Media; DNA; DNA Replication; Female; Floxuridine; Hydroxyurea; Mitosis; Ovary; Phosphorus Radioisotopes; Thymidine; Time Factors | 1973 |
Hydroxyurea-induced accumulation of short fragments during polyoma DNA replication. II. Behavior during incubation of isolated nuclei.
Topics: Animals; Cell Nucleus; Centrifugation, Density Gradient; Chromatography, Ion Exchange; Culture Techniques; DNA Replication; DNA, Viral; Fibroblasts; Hydroxyurea; Mice; Phosphorus Radioisotopes; Polyomavirus; Thymidine; Tritium | 1973 |
DNA replication in SV40-infected cells. IX. The inhibition of a gap-filling step during discontinuous synthesis of SV40 DNA.
Topics: Animals; Cell Line; Cell-Free System; Centrifugation, Density Gradient; Coliphages; Culture Techniques; DNA Nucleotidyltransferases; DNA Repair; DNA Replication; DNA, Viral; Escherichia coli; Haplorhini; Hydroxyurea; Kidney; Models, Chemical; Nucleic Acid Hybridization; Oligonucleotides; Phosphorus Radioisotopes; Polynucleotide Ligases; Simian virus 40; Thymidine; Tritium; Virus Cultivation | 1973 |
Further studies of histone phosphorylation in the presence of inhibitors of DNA synthesis.
Topics: Carcinoma, Hepatocellular; Cells, Cultured; Cycloheximide; DNA, Neoplasm; Enzyme Activation; Histones; Hydroxyurea; Kinetics; Liver Neoplasms; Lysine; Neoplasm Proteins; Neoplasms, Experimental; Phosphates; Phosphoric Monoester Hydrolases; Phosphorus Radioisotopes; Thymidine; Tritium | 1974 |
DNA repair in Potorous tridactylus.
Topics: Animals; Bromodeoxyuridine; Carbon Radioisotopes; Cell Line; Centrifugation, Density Gradient; DNA; DNA Repair; DNA Replication; Endonucleases; Humans; Hydrogen-Ion Concentration; Hydroxyurea; Isotope Labeling; Kidney; Light; Marsupialia; Phosphorus Radioisotopes; Radiation Effects; Skin; Thymidine; Time Factors; Tritium; Ultraviolet Rays; Xeroderma Pigmentosum | 1974 |
[Treatment of chronic myeloid leukemia].
Topics: Antineoplastic Agents; Busulfan; Humans; Hydroxyurea; Leukemia, Myeloid; Phosphorus Radioisotopes | 1973 |
The effects of inhibitors of RNA and DNA synthesis on protein synthesis and polysome levels in mouse L-cells.
Topics: Animals; Benzimidazoles; Centrifugation, Density Gradient; Cycloheximide; Cytarabine; Dactinomycin; Deoxyadenosines; DNA; DNA Replication; Dose-Response Relationship, Drug; Half-Life; Hydroxyurea; Kinetics; L Cells; Mice; Peptide Chain Elongation, Translational; Peptide Chain Initiation, Translational; Peptide Chain Termination, Translational; Phosphorus Radioisotopes; Polyribosomes; Protein Biosynthesis; Pyridines; RNA; RNA, Ribosomal; Sulfhydryl Compounds; Transcription, Genetic; Tritium | 1973 |
The relationship between DNA synthesis and incorporation of (14C)lysine into different histone fractions in Ehrlich ascites tumour cells.
Topics: Animals; Arginine; Aspartic Acid; Carbon Radioisotopes; Carcinoma, Ehrlich Tumor; Cell Nucleus; DNA; Electrophoresis, Starch Gel; Glutamates; Histones; Hydroxyurea; Lysine; Mice; Mice, Inbred BALB C; Microscopy, Phase-Contrast; Phosphorus Radioisotopes; Time Factors | 1974 |
The effect of inhibition of deoxyribonucleic acid synthesis on histone phosphorylation.
Topics: Amino Acids; Cells, Cultured; Cycloheximide; DNA; Dose-Response Relationship, Drug; Electrophoresis; Half-Life; Histones; Hydroxyurea; Lysine; Phosphates; Phosphorus Radioisotopes; Protein Biosynthesis; RNA; Thymidine; Time Factors; Tritium; Uridine | 1973 |
Cell-cycle-dependent variations of deoxyribonucleoside triphosphate pools in Chinese hamster cells.
Topics: Animals; Cell Count; Cell Division; Cell Line; Chromatography, Paper; Cricetinae; Deoxyribonucleotides; DNA Nucleotidyltransferases; Female; Hydroxyurea; Isotope Labeling; Micrococcus; Mitosis; Ovary; Phosphorus Radioisotopes; Templates, Genetic; Time Factors; Tritium | 1973 |
[Essential thrombocythemia. Clinical, biological study and developmental study of 61 cases].
Topics: Busulfan; Female; Hematologic Tests; Humans; Hydroxyurea; Male; Middle Aged; Phosphorus Radioisotopes; Thrombocytosis; Time Factors | 1984 |
Pulsed field gel electrophoresis labeling method to study the pattern of Saccharomyces cerevisiae chromosomal DNA synthesis during the G1/S phase of the cell cycle.
Topics: Agglutinins; Cell Cycle; DNA Replication; DNA, Fungal; Electrophoresis, Gel, Pulsed-Field; G1 Phase; Genome, Fungal; Hydroxyurea; Kinetics; Mating Factor; Mutation; Nocodazole; Peptides; Phosphorus Radioisotopes; Saccharomyces cerevisiae; Time Factors | 1995 |
Survival and risk of leukaemia in polycythaemia vera and essential thrombocythaemia treated with oral radiophosphorus: are safer drugs available?
Topics: Administration, Oral; Aged; Busulfan; Female; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Leukemia, Radiation-Induced; Male; Neoplasms, Second Primary; Phosphorus Radioisotopes; Polycythemia Vera; Thrombocytosis; Time Factors | 1995 |
Leukemogenic risk of hydroxyurea therapy in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis.
Topics: Acute Disease; Anemia, Refractory, with Excess of Blasts; Busulfan; Cell Transformation, Neoplastic; Chlorambucil; Cohort Studies; Disease Progression; Drug Therapy, Combination; Enzyme Inhibitors; Female; Humans; Hydroxyurea; Incidence; Interferon-alpha; Leukemia; Leukemia, Radiation-Induced; Male; Melphalan; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera; Preleukemia; Primary Myelofibrosis; Retrospective Studies; Ribonucleotide Reductases; Risk; Thrombocythemia, Essential | 1996 |
Acute lymphoblastic leukemia in a case of essential thrombocythemia.
Topics: Aged; Antigens, CD; Blast Crisis; Bone Marrow; Female; Humans; Hydroxyurea; Lymphocyte Activation; Phosphorus Radioisotopes; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Thrombocytosis | 1996 |
Polycythemia vera: a retrospective and reprise.
Topics: Aspirin; Blood Volume; Controlled Clinical Trials as Topic; Female; Hematocrit; History, 19th Century; History, 20th Century; Humans; Hydroxyurea; Male; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera | 1997 |
Survival in a patient with polycythaemia vera for over thirty years: implications for treatment decisions in younger patients.
Topics: Adult; Busulfan; Female; Humans; Hydroxyurea; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera; Survivors; Treatment Outcome | 1998 |
Leukemia and myelodysplasia in patients with essential thrombocythemia treated with cytotoxic agents.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Busulfan; Female; Follow-Up Studies; Humans; Hydroxyurea; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Chronic; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Phosphorus Radioisotopes; Pipobroman; Retrospective Studies; Thrombocythemia, Essential | 1999 |
Plasma erythropoietin concentrations in polycythaemia vera with special reference to myelosuppressive therapy.
Topics: Adult; Aged; Busulfan; Erythropoietin; Female; Humans; Hydroxyurea; Immunosuppressive Agents; Interferon-alpha; Male; Middle Aged; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera | 2000 |
Leukemia and myelodysplasia effect of multiple cytotoxic therapy in essential thrombocythemia.
Topics: Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Busulfan; Fatal Outcome; Female; Humans; Hydroxyurea; Leukemia; Male; Middle Aged; Myelodysplastic Syndromes; Neoplasms, Second Primary; Phosphorus Radioisotopes; Pipobroman; Thrombocythemia, Essential | 2000 |
[Hydroxyurea--is it a harmless drug in Vaquez disease?]].
Topics: Aged; Alopecia; Combined Modality Therapy; Cystitis; Erectile Dysfunction; Female; Fever; Follow-Up Studies; Humans; Hydroxyurea; Incidence; Leg Ulcer; Leukemia; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neural Tube Defects; Phosphorus Radioisotopes; Pipobroman; Polycythemia Vera; Prospective Studies; Risk; Safety; Stomatitis, Aphthous | 2001 |
Comparative genomic hybridization in polycythemia vera and essential thrombocytosis patients.
Topics: Aged; Aged, 80 and over; Chromosome Aberrations; Female; Humans; Hydroxyurea; Male; Middle Aged; Nucleic Acid Hybridization; Phlebotomy; Phosphorus Radioisotopes; Polycythemia Vera; Thrombocytosis | 2001 |